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Polyaromatic hydrocarbons (PAHs) are ubiquitous toxic pollutants that are 
slow to degrade naturally and costly to remediate artificially. Several species of 
bacteria have been shown to degrade PAHs, including Sphingomonas 
paucimobilis EPA505. The aerobic bacterial catabolism of the PAH naphthalene 
has been studied in several PAH metabolizing bacteria but never in EPA505. 
This study addresses this deficiency by identifying and characterizing one of the 
genes for naphthalene metabolism—nahD. NahD codes for the enzyme 
2-hydroxychromene-2-carboxylate (HCCA) isomerase, which is the fourth of six 
enzymes in the upper catabolic pathway of naphthalene. 
In this study, the gene nahD is identified and sequenced from EPA505. Then 
it is sub-cloned into Escherichia coli for expression and purification of HCCA 
isomerase. Sub-cloning was done by utilizing a pET-30 vector with a histidine 
tagged leader peptide and an enterokinase cleavage site at the insert cloning 
site. This allows for induction by isopropylthiogalactoside (IPTG), simple 
purification by Ni2+ affinity chromatography and restoration of the native enzyme 
form by peptide cleavage with enterokinase. The results suggest that nahD and 
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Polycyclic aromatic hydrocarbons (PAHs) are a seemingly ubiquitous soil 
contaminant with many toxic properties. These compounds pose a long-term 
presence because of low water solubility and slow degradation. The four 
bacterial genera comprising the sphingomonads have a unique capacity for 
degrading PAHs and thus have a promising future for bioremediation of these 
contaminants in the soil. Traditional methods of remediation involve costly 
excavation and incineration of contaminated soil and sediment. Bioremediation 
by resident microbes could be much less invasive on the ecosystem and would 
carry substantial economic savings with it. However, a comprehensive 
bioremediation scheme has yet to be outlined. Some attempts have been made 
at bioremediation, usually in conjunction with traditional physiochemical methods. 
While these bioremediation endeavors can cut costs, they cannot compete with 
the effectiveness of reducing PAH levels attained by incineration. 
A better understanding of the genetic mechanisms guiding PAH metabolism 
in sphingomonads may allow successful bioremediation of the contaminants. 
Research efforts have already begun to unravel the biochemistry and genetics of 
PAH catabolism in aerobic bacteria—mainly Sphingomonas and Pseudomonas. 
In sphingomonads, the ability to degrade a wide range of high molecular weight 
PAHs and other recalcitrant xenobiotic compounds has led to a complex genetic 
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arrangement—possibly upwards of seventy-five genes in some species. Many 
gene products have been determined to have specific enzyme functions in the 
biochemical pathways that have already been deduced. Other genes have 
unknown function, and still others are predicted to be present but have not been 
located.  
This study attempts to clarify the genetics of PAH catabolism in S. 
paucimobilis EPA505 by sequencing, sub-cloning, expressing and purifying the 
fourth enzyme in naphthalene catabolism—2-hydroxychromene-2-carboxylate 
isomerase. This enzyme catalyzes the conversion of the cis-trans isomers: 
2-hydroxychromene-2-carboxylate to trans-o-hydroxybenzylidenepyruvate. It is 
assumed that the naphthalene catabolic pathway and other PAH catabolic 
pathways in EPA505 are similar to those of other species, but this has not yet 
been demonstrated. This study will continue research into the genetics of PAH 





Polycyclic aromatic hydrocarbons 
Polycyclic aromatic hydrocarbons are a group of compounds consisting of two 
or more benzene rings fused into various orientations. There are hundreds of 
combinations possible, and they are generally found as a mixture. Some of the 
more common PAHs are naphthalene, anthracene, phenanthrene, and fluorene. 
The most common method of formation is the incomplete combustion of wood, 
coal or petroleum products. Because of their low water solubility, PAHs tend to 
endure in the soil for long periods of time, and they are released into aquifers 
slowly, causing lasting effects on the environment. 
The toxic properties of PAHs on humans and animals have been fairly well 
documented. The most notable hazards are carcinogenic and mutagenic effects. 
PAHs are also suspected of causing reproductive, developmental and 
immunogenic problems[44]. The U.S. Environmental Protection Agency’s (EPA) 
National Partnership for Environmental Priorities has included 27 PAHs on its list 
of priority chemicals that need to be addressed[54]. (See Table 2.1) 
The Toxic Substances Control Act (TSCA) and the Emergency Planning and 
Community Right to Know Act (EPCRA) provide the authority for the EPA to 
monitor hazardous chemicals like PAHs. Industries and facilities are required to 
report use of PAHs for the Toxic Release Inventory (TRI). In 2004 the National 
Priority Chemicals Trends Report by the EPA identified 684 facilities across the 
4 
 




























nation that reported PAHs[54]. PAHs are also identified by the Priority List of 
Hazardous Substances for the Comprehensive Environmental Response, 
Compensation and Liability Act (CERCLA), and they are one of the most 
common chemical hazards at Superfund sites on the National Priorities List. 
The greatest total amount of PAHs is found in the atmosphere from the 
burning of wood and fossil fuels. These pollutants can remain airborne for long 
lengths of time by adsorbing to soot or other particulates[4]. Eventually the PAHs 
settle out by precipitation or dry deposit[4]. Although the greatest total amount is 
in the atmosphere, the concentration is quite low compared to local areas of 
heavy pollution usually found around certain industrial sites[23]. It is in these areas 
of concentrated pollution that soil and water contamination yields the greatest 
concern for exposure[29]. 
Common sites of heavy PAH pollution would include manufactured gas 
facilities, coking industrial sites and wood preserving plants that use creosote. 
Significant quantities of PAHs can also be found along roads and highways from 
vehicular emissions[23]. Background levels of PAHs can even be found in remote 
5 
 
areas due to natural formation of PAHs from forest fires or volcanic ash[23,29]. 
Interestingly, these background levels (median of 1mg/kg soil) can far exceed the 
10-3mg/kg risk assessment goals for remediation[23,29]. For this reason, 
remediation goals are often set to meet background levels of pollution rather than 
the much lower risk assessment levels. 
Sphingomonads 
The bacterial group “sphingomonads” refers collectively to four genera: 
Sphingomonas, Sphingobium, Sphingopyxis and Novosphingobium[5,6]. One of 
the defining characteristics of sphingomonads is their ability to degrade 
aromatics—polycyclic aromatics in particular. The ability to utilize a wide variety 
of PAHs as sole carbon and energy sources led to the discovery of and interest 
in many sphingomonad species[43,46,60]. Sphingomonads are of great interest to 
researchers looking for a bioremediation solution to PAH contaminants[21], due to 
their biodegradative potential in this area. 
Taxonomy and phylogeny 
Sphingomonas paucimobilis is the type species of the family 
Sphingomonadaceae of the order Sphingomonadales of the class Alpha-
proteobacteria[9]. Sphingomonas paucimobilis was originally classified as a 
Pseudomonas[9,63], and the PAH catabolic metabolism of several Pseudomonas 
species (e.g. P. putida, P. aeruginosa, P. stutzeri, etc.)[19] is testament to the 
similarity of the two genera. Sphingomonas was originally listed as a single 
genus but was then divided into the four genera previously mentioned based on 
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phylogenetic and chemotaxonomic analyses[50]. Sphingomonas species are 
gram-negative and generally rod-shaped or slightly curved. Some cells have 
flagella as indicated by the etymology of “paucimobilis.” They form small (1mm), 
circular, domed, smooth colonies with entire margin and are yellow in color when 
cultured on agar media. Sphingomonads possess glycosphingolipids in their 
outer cell membrane rather than the usual lipopolysaccharides. All documented 
species are chemoheterotrophic and strictly aerobic. 
Habitat and ecology of sphingomonads 
Sphingomonads are found in a wide range of habitats: topsoil[31,40], 
subsurface[6,14], root systems[51,55], rivers[17,64], freshwater bodies[3,30,61], marine 
water[57], ocean sediments[11] and more. Clinical specimens have also been 
described[63] but are not of concern to PAH metabolism. Sphingomonads are 
found in habitats with the full range of nutrient concentrations—from 
ultraoligotrophic to copiotrophic environments. The range of conditions in which 
sphingomonads are able to flourish indicates their robust and diversified 
metabolic capabilities.  
Quite often sphingomonads are found in areas that have been contaminated 
with PAHs or other recalcitrant organic compounds[32]. Three species were 
discovered and characterized from deep subsurface sediments at the Savannah 
River Site in the Atlantic Coastal Plain[6]. These three new species—
Sphingomonas aromaticovorans, S. stygia and S. subterranean—have been 
documented to degrade many aromatics and other related compounds such as 
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benzoate, p-cresol, xylene, etc[46]. Several other sphingomonads were also found 
at the site, but these were not novel species. S. paucimobilis EPA505 was 
discovered at a creosote contaminated site in Pensacola, Florida[36,37]. It also was 
found to be capable of growth on a wide range of aromatic substrates as its sole 
carbon and energy source[47]. Other strains of S. paucimobilis have been isolated 
from PCB contaminated soil[1,59], -hexachlorocyclohexane contaminated soil[8,39] 
and wastewater liquor[12,15]. Species of Sphingobium have been isolated from 
various pentachlorophenol contaminated soils[10,42], and S. yanoikuyae B1 was 
isolated from a polluted stream for its ability to utilize PAHs as the sole carbon 
and energy source[16]. While there are many sphingomonads whose niche is PAH 
degradation, it is not the only ecological role these organisms fill, although it is 
the most relevant role to this topic. 
Sphingomonads can also be dominant players in soil and aqueous 
environments apart from PAH contamination[5]. In fact, Sphingomonas species 
were first identified in clinical specimens before its propensity for PAH catabolism 
was discovered[63]. Sphingomonas alaskensis is a dominant species found in 
marine waters[57] and many other sphingomonads are commonly found in 
uncontaminated soils (e.g. S. dokdonensis[66] and S. insulae[65]) or rhizospheres 
(e.g. S. azotifigens[62] and S. mali[51]). Microbial community analysis by 16S rRNA 
and Denaturing Gradient Gel Electrophoresis (DGGE) have shown more than 




Biochemistry of PAH catabolism 
The biochemistry for the complete aerobic degradation of some PAHs such 
as naphthalene and phenanthrene has been previously published[19]. The 
metabolic pathway is divided into the upper and lower catabolic pathways. The 
upper catabolic pathway begins with naphthalene (or one of a few other PAHs) 
and converts it via several intermediates to salicylic acid. The lower catabolic 
pathway converts salicylic acid into several TCA cycle intermediates through 
branching pathways. Complete catabolism is only possible with a full 
complement of the necessary genetically coded enzymes, which not all bacteria 
possess.  
The upper catabolic pathway for naphthalene metabolism is as follows: 
naphthalene is converted to cis-1,2-dihydroxy-1,2-dihydronaphthalene by 
naphthalene dioxygenase; cis-1,2-dihydroxy-1,2-dihydronaphthalene is 
converted to 1,2-dihydroxynaphthalene by naphthalene dihydrodiol 
dehydrogenase; 1,2-dihydroxynaphthalene is converted to 2-hydroxychromene-
2-carboxylate by 1,2-dihydroxynaphthalene dioxygenase; 2-hydroxychromene-2-
carboxylate is converted to trans-o-hydroxybenzylidenepyruvate by 2-
hydroxychromene-2-carboxylate isomerase; trans-o-hydroxybenzylidenepyruvate 
is converted to salicylaldehyde by trans-o-hydroxybenzylidenepyruvate 
hydratase-aldolase; and lastly, salicylaldehyde is converted to salicylic acid by 




Figure 2.1: Upper catabolic pathway of naphthalene. Enzymes: (A) naphthalene 
dioxygenase, (B) cis-naphthalene dihydrodiol dehydrogenase,  
(C) 1,2-dihydroxynaphthalene dioxygenase, (D) 2-hydroxychromene-2-
carboxylate isomerase, (E) trans-o-hydroxybenzylidenepyruvate hydratase 
aldolase, (F) salicylaldehyde dehydrogenase. 
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The first enzyme for naphthalene degradation—naphthalene dioxygenase—is 
actually an enzyme complex composed of four subunits: a ferredoxin-reductase, 
a ferredoxin and two iron-sulfur proteins. The two iron-sulfur proteins are specific 
for naphthalene substrate, but alternate iron-sulfur proteins may complex with the 
same ferredoxin/ferredoxin-reductase subunits to bind and metabolize other 
PAHs such as phenanthrene and anthracene[19]. The rest of the enzymes in the 
upper catabolic pathway appear to work with multiple PAHs. 
The branching lower catabolic pathway for aerobic PAH degradation is as 
follows: (1) salicylic acid is converted to gentisic acid by salicylate 5-hydroxylase; 
gentisic acid is converted to maleylpyruvate by gentisate 1,2-dioxygenase; 
maleylpyruvate is converted to fumarylpyruvate by maleylpyruvate isomerase; 
and lastly, fumarylpyruvate is converted to pyruvate and fumarate by 
fumarylpyruvate hydrolase; or (2) salicylic acid is converted to catechol by 
salicylate hydroxylase; catechol is converted to 2-hydroxymuconic-semialdehyde 
by catechol 2,3-dioxygenase; 2-hydroxymuconic-semialdehyde is converted to 2-
oxo-4-pentoic acid by semialdehyde hydrolase or through two other 
intermediates by hydroxymuconic semialdehyde dehydrogenase, 4-
oxalocrotonate isomerase and 4-oxalocrotonate decarboxylase; 2-oxo-4-pentoic 
acid is then converted to 4-hydroxy-2-oxovaleric acid by 2-oxopent-4-enoate; 4-
hydroxy-2-oxovaleric acid is converted to pyruvic acid and acetaldehyde by 2-
oxo-4-hydroxypentanoate aldolase; and lastly, acetaldehyde is converted to 
acetyl-CoA by acetaldehyde dehydrogenase; or (3) salicylic acid is converted to 
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catechol by salicylate hydroxylase; then catechol is alternatively converted to 
cis,cis-muconic acid by catechol 1,2-dioxygenase; cis,cis-muconic acid is 
converted to muconolactone by cis,cis-muconate lactonizing enzyme; 
muconolactone is converted to -ketoadipate-enol-lactone by muconolactone 
isomerase; -ketoadipate-enol-lactone is converted to -ketoadipic acid by -
ketoadipate-enol-lactone hydrolase; -ketoadipic acid is converted to -
ketoadipyl-CoA by -ketoadipate:succinyl-CoA transferase; and lastly, -
ketoadipyl-CoA is converted to succinyl CoA and acetyl-CoA by b-ketoadipyl-
CoA thiolase. (See Figure 2.2) 
The upper and lower catabolic pathways have been more thoroughly studied 
in Pseudomonas, but initial research indicates that it is the same or very similar 
for sphingomonads[43]. There are also at least a few other species that catabolize 
PAHs, including Comamonas, Burkholderia, Mycobacterium and Rhodococcus. 
The catabolic pathways for a few other PAHs such as pyrene and fluorene 
have also been at least partially deduced[19,24], but will not be discussed in further 
detail here.  
Genetics of PAH catabolism 
The “classical” PAH catabolic genes for naphthalene degradation (nah genes) 
have been well studied in Pseudomonas. Their organization consists of three 
well defined operons: one for the upper catabolic genes, another for the lower 
catabolic genes and a third for a regulator gene[19]. Operons for metabolism of a 




Figure 2.2: Lower catabolic pathway of naphthalene. Enzymes: (G) salicylate 
hydroxylase, (H) catechol 2,3-dioxygenase, (I) hydroxymuconic semialdehyde 
dehydrogenase, (J) 4-oxalocrotonate isomerase, (K) 4-oxalocrotonate 
decarboxylase, (L) hydroxymuconic semialdehyde hydrolase, (M) 2-oxopent-4-
enoate hydratase, (N) 2-oxo-4-hydroxypentanoate aldolase, (O) acetaldehyde 
dehydrogenase, (P) catechol 1,2-dioxygenase, (Q) cis,cis-muconate lactonizing 
enzyme, (R) muconolactone isomerase, (S) -ketoadipate-enol-lactone 
hydrolase, (T) -ketoadipate:succinyl-CoA transferase, (U) -ketoadipyl-CoA 
thiolase, (V) salicylate 5-hydroxylase, (W) gentisate 1,2-dioxygenase,  
(X) maleylpyruvate isomerase, (Y) fumarylpyruvate hydrolase. 
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However, genetic organization in the sphingomonads is much more complex. 
Naphthalene catabolic genes are strewn into a convoluted arrangement with 
genes for metabolism of many other aromatics such as toluene, biphenyl, xylene, 
etc[43]. Although arranged differently, the individual enzymatic genes in 
sphingomonads have high sequence homology to those in Pseudomonas. 
The PAH catabolic genes of sphingomonads may be located either 
chromosomally located or extra-chromosomally. A 40-kb region on the 
chromosome of Sphingobium yanoikuyae was sequenced and found to contain 
35 genes for catabolism of aromatic compounds[25]. Several Sphingomonas 
paucimobilis EPA505 genes have been sequenced or partially sequenced from 
the chromosome[48,49]. had The complete sequence of the 184-kb plasmid (pNL1) 
from Novosphingobium aromaticovorans F199 containing 79 genes for 
catabolism of aromatics was published[45]. Significant amounts of sequencing of 
PAH catabolic genes have also been accomplished in Sphingomonas 
chungbukensis DJ77[43], Sphingobium agrestis HV3[67], S. xenophaga BN6[28,22], 
and S. sp. P2[43]. Much interpretation is still needed from all this sequencing, and 
many predicted genes are yet to be found in some species. 
All of the species listed above have a high degree of homology in both 
nucleotide sequence and genetic organization. This could possibly be accounted 
for by horizontal gene transfer, because PAH catabolic genes are sometimes 
located on self-transmissible plasmids or adjacent to transposable elements[19,43].  
14 
 
Advances in bioremediation 
In order to understand the potential advantages of biological remediation, it is 
first necessary to briefly discuss the conventional methods usually employed for 
remediation and the EPA’s remediation protocols for Superfund sites. Since 
1980, regulation of hazardous waste sites has been under the jurisdiction of the 
EPA as outlined in the Comprehensive Environmental Response, Compensation 
and Liability Act (CERCLA) since 1980. A Hazard Ranking System evaluates and 
ranks hazardous waste sites for addition to the National Priorities List (NPL). 
Sites on the NPL then undergo a remedial investigation (RI) and a feasibility 
study (FS). The RI appraises the general condition and hazards/toxins present at 
the site, as well as a risk assessment of any toxins found. The FS recommends 
options for remediation. A record of decision (ROD) is then signed as the final 
authority for the guidelines of remediation. The ROD would include detailed 
instructions as to what hazards need to be remediated, where the hazards are 
located, what processes will be used to remediate, and what acceptable levels of 
remaining contamination are allowed. 
RODs often implement an excavation and incineration technique if PAH 
contamination requires remediation beyond institutional controls or containment 
of the toxins. A typical excavation could remove tens or hundreds of thousands of 
tons of soil or other solid waste up to a few meters deep. Incineration of the 
soils/solid-waste would then involve the removal of moisture content from the 
waste in a hot kiln. Then the temperature would be increased to approximately 
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600-800oC to volatilize all PAHs and other toxins present. The resulting ash 
would be tested to ensure sufficient decontamination, and air pollution prevention 
and monitoring measures must also be in place. Excavation and incineration of 
soils and solid waste is a very effective treatment to reduce PAH levels, but it is 
also very expensive, costing hundreds of dollars per ton of soil or solid waste. 
An alternative to incineration, which is sometimes employed, is soil washing 
with solvents or surfactants. Excavation of soil is still required, but operating 
costs to flush the waste out with washing techniques could be lower than high 
temperature incineration techniques. Once the PAHs have been sufficiently 
removed from the soil/waste, they may be disposed of in any number of ways. 
The downside to washing methods is that they do not remove contaminants as 
efficiently as incineration. Also, the solvents or surfactants often have toxic 
properties themselves, complicating the remediation process[58]. 
Bioremediation schemes have yet to be demonstrated worthy of supplanting 
physiochemical methods of remediation, but continued efforts are being poured 
into research to achieve viability. Biodegradation of PAHs by sphingomonads or 
other organisms is limited to only the bioavailable portion of PAHs in the soil. 
Bioavailabilty is very low because of the hydrophobic nature of high molecular 
weight PAHs which cause them to adsorb to dirt particles rather than to solubilize 
in water[23]. Generally only the aqueous phase is accessible to microbes. Despite 
this hindrance, biodegradation does occur at low rates. A more complete 
understanding of the microbial metabolism and physiology of PAHs may reveal 
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methods to enhance biodegradation.  
For now, bioremediation is being implemented in conjugation with traditional 
methods like soil washing. For example, the contaminated soil could be 
excavated and washed with surfactants; then the wash, now containing PAHs, 
could be treated in a bioreactor[18,68,69]. However, high costs would still be 
associated with such a process. Farming techniques, which add nutrients to the 
soil and tilling to aerate, have been used to stimulate microbial biodegradation, 
but only minimal reductions of toxins have been attained through these 
processes[20]. The ultimate goal of bioremediation would be an in situ technique 
that would somehow stimulate biodegradation by a native microbial community. If 
such a scheme could reduce PAH concentrations to an acceptable level, it would 
most likely have tremendous cost advantages as well as being much less 
invasive to the ecosystem compared to an excavation processes. 
Sphingomonas paucimobilis EPA505 and nahD 
S. paucimobilis EPA505 was isolated from a creosote contaminated site, and 
subsequent studies have shown it capable of metabolizing many aromatic 
substrates. EPA505 was able to utilize the following as sole carbon and energy 
sources: phenanthrene, naphthalene, fluoranthene, toluene, benzoic acid, 2,3-
dihydroxybenzoic acid, 3,4-dihydroxybenzoic acid, 1-chloro-2,4-dinitrobenzene, 
anthracene, 2-hydroxy-3-naphthoic acid and 1-hydroxy-2-naphthoic acid, salicylic 
acid and catechol[47]. (See Figure 2.3 for compounds and structures.) The 




Figure 2.3: PAHs utilized as growth substrates by S. paucimobilis EPA505. 
 
mutagenesis studies. These studies revealed the partial sequence of four 
putative genes and two promoters[48,49]. Probes designed to hybridize with 
conserved region of dioxygenases followed by chromosome walking revealed the 
sequence of several more putative genes for PAH metabolism (unpublished 
data). Among those genes was a sequence resembling the fourth enzyme in the 
upper catabolic pathway for naphthalene degradation—nahD or 2-
hydroxychromene-2-carboxylate isomerase (HCCA isomerase).  
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HCCA isomerase has been studied in at least three strains of Pseudomonas 
and one Sphingomonas (P. putida[53], P. putida G7[13], P. sp. TA-2[41] and S. 
yanoikuyae B1[26]) and the gene sequence has been published for several other 
sphingomonads.  The enzyme catalyzes the isomerization of 2-
hydroxychromene-2-carboxylate (HCCA) to trans-o-hydroxybenzylidenepyruvate 
(tHBP). It appears to be a dimeric enzyme with reduced glutathione (GSH) acting 
as a cofactor. Studies in S. yanoikuyae B1 also indicate that HCCA isomerase is 
also capable of catalyzing the isomerization of 1,2-dihydroxyanthracene to 2-
hydroxybenzochromene-2-carboxylate in the anthracene catabolic pathway. 
Research objectives 
The purpose of this study was to sequence the putative HCCA isomerase 
gene from S. paucimobilis EPA505 and sub-clone it into a protein expression 
vector for induction and purification. Sequencing was accomplished by 
polymerase chain reaction (PCR) amplification with primers targeting regions just 
upstream and downstream of the putative nahD gene. Sub-cloning into E. coli 
NovaBlue™ and E. coli BL21(DE3)pLysS was achieved with a pET-30 Ek/LIC 
vector. Expression of nahD was by induction with isopropyl--D-
thiogalactopyranoside (IPTG) and analyzed by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). Purification was done by 
utilizing Ni2+ affinity chromatography, taking advantage of the histidine tag on the 





MATERIALS AND METHODS 
Sequencing and analyzing nahD 
Preliminary sequence data indicated the presence of nahD in Sphingomonas 
paucimobilis EPA505 (unpublished data). Genomic DNA was extracted from EPA 
505 for polymerase chain reaction (PCR) amplification and sequencing of the 
product. The nucleotide sequence and its translation were then compared to 
previously published sequences to determine the identity. 
Stock culture of S. paucimobilis EPA505 was removed from -80oC storage in 
a glycerol-based medium (15% v/v glycerol and 85% LB culture—10 g/L 
Bacto™Tryptone from Becton, Dickinson and Company (BD, Sparks, MD), 5 g/L 
yeast extract from Difco (Detroit, MI) and 10 g/L NaCl) and was streaked onto LB 
agar (15 g/L agar from Difco) and incubated at 37oC for 24 hrs. An isolated 
colony was inoculated into 5 mL LB and incubated overnight at 37oC with gentle 
agitation (60 rpm) in G24 Environmental Incubator Shaker from New Brunswick 
Scientific (Edison, NJ). Genomic DNA extraction from the EPA505 culture was 
then performed as follows with Ultra Clean™ Microbial DNA isolation kit (Catalog 
#12224-50) from Mo Bio Laboratories (Carlsbad, CA) according to 
manufacturer’s instructions.  
A 2 mL collection tube with 1.8 mL of culture was centrifuged at 10,000 x g for 
30 seconds. The supernatant was decanted and centrifuged at 10,000 x g for 
another 30 seconds. The remaining supernatant was pipetted out and discarded. 
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The cell pellet was resuspended in 300 μl MicroBead solution and vortexed 
gently to mix. Then the resuspended cells were transferred to a MicroBead tube 
and 50 μl Solution MD1 was added. The bead-beating tube was then secured 
horizontally onto a vortex adapter and vortexed on maximum for 10 minutes to 
lyse the cells using the Vortex-Genie from Fisher Scientific (Bohemia, NY).  The 
tube was then centrifuged at 10,000 x g for 30 seconds, and the supernatant was 
transferred to a clean 2 mL collection tube. Then 100 μL Solution MD2 was 
added, vortexed briefly to mix, then incubated at 4oC for 5 minutes. The tube was 
then centrifuged at 10,000 x g for one minute to pellet any remaining cellular 
debris. The supernatant was then transferred to a clean collection tube and 
450 μL Solution MD3 was added. Tube was vortexed briefly to mix. The 
supernatant was loaded into the Spin Filter in two aliquots, followed by 
centrifugation at 10,000 x g, and the flow through was discarded. Filter-bound 
DNA was then washed with 300 μL Solution MD4 and centrifuged at 10,000 x g 
for 30 seconds. The flow through was discarded and the tube centrifuged again 
for 1 minute to dry. The Spin Filter was then transferred to a clean collection tube 
and 50 μL Solution MD5 was added to the center of the filter membrane followed 
by centrifugation at 10,000 x g for 30 seconds. The flow through was then 
checked for DNA concentration and purity by OD260 and OD260/280 as well as 
agarose gel electrophoresis. The OD260 and OD260/280 measurements throughout 
this study were performed with a Biophotometer (Cat. #95200000-4) from 
Eppendorf (Hamburg, Germany). Agarose gels were always 1% agarose from 
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Sigma Chemical (St. Louis, MO) in 1X TBE buffer (90 mM Tris-borate, 4 mM 
EDTA, pH 8.0) with 0.5 μg/mL ethidium bromide. Samples of 5 μL were then 
added to 1 μL 6X loading dye and transferred to the agarose gel. Gel 
electrophoresis was conducted at 150V for approximately one hour. 
PCR primers were designed to target sites upstream and downstream of the 
putative 588 base pairs (bp) of coding sequence for amplification. Primers were 
designed with Primer3 (http://frodo.wi.mit.edu/primer3/input.htm). The forward 
primer (5’ TCC AGC AGA TTC AAA ACA CG 3’) with Tm of 53.4
oC, designated 
“Fred,” targeted the non-coding strand approximately 350 bp upstream of the 
suspected start codon. The reverse primer (5’ GCT TAG CGG TTT CGA TTG AC 
3’) with Tm of 54.2
oC, designated “Renée,” targeted the coding strand 
approximately 50 bp downstream of the suspected stop codon. The forward 
primer Fred and reverse primer Renée were obtained from Integrated DNA 
Technologies (IDT, Coralville, IA) and diluted in nuclease-free H2O to 10 μMol. 
The entire PCR amplified product should be slightly less than 1000 bp based on 
the preliminary sequencing data. 
The PCR reactions were assembled with the following: 2 μL isolated EPA 505 
DNA template, 2 μL forward primer Fred (10 μMol), 2 μL reverse primer Renée 
(10 μMol), 19 μL H2O and 25 μL GoTaq® Green MasterMix (Cat. #M7122) from 
Promega (Madison, WI). PCR reactions were carried out in a Genius 
thermocycler with heated lid from Techne (Princeton, NJ). Reactions were as 
follows: 95oC initial denaturation for 2 minutes; 30 cycles of 95oC for 45 seconds, 
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58oC for 45 seconds and 72oC for 45 seconds; final elongation at 72oC for 2 
minutes, and then held at 4oC. 
The PCR product was then purified using QIAquick® PCR purification kit 
(Cat. #28706) from QIAGEN (Valencia, CA) following manufacturer’s instructions 
as follows: The 50 μL PCR reaction was added to 250 μL Buffer PB and the mix 
was transferred to a QIAquick spin column in a 2 mL collection tube. The DNA 
was bound to the filter by centrifugation at 10,000 x g for 1 minute, and the flow 
through was discarded. Then the DNA was washed with 750 μL Buffer PE and 
centrifuged for 1 minute. Flow through was discarded, and the filter was 
centrifuged again for one minute to dry. The QIAquick column was then 
transferred to a clean 1.5 mL microfuge tube, and 50 μL of TlowE buffer (10 
mMol Tris-HCl, 0.1 mM EDTA, pH8.0) was added to the center of the filter 
membrane. After one minute, the tube was centrifuged at 10,000 x g for 1 
minute. The flow through was then checked for DNA concentration and purity by 
OD260 and OD260/280 as well as agarose gel electrophoresis. 
The PCR amplification and purification was done in triplicate. Two samples 
were sent to Clemson University Genomics Institute (CUGI, Clemson, SC) along 
with primers Fred and Renée for sequencing, and one sample was sent to 
Macrogen (Seoul, Korea). The six resulting sequences were then assembled in 
Sequencher™ 4.7 from Gene Codes Corporation (Ann Arbor, MI) and edited 
manually. 
The National Center for Biotechnology Information (NCBI) Basic Local 
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Alignment Search Tool (BLAST, http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used 
to compare the final sequence to previously published sequences using 
nucleotide-nucleotide (blastn) and translated nucleotide (tblastx) queries. Three 
of the top matches were used to perform a ClustalW2 alignment from the 
European Bioinformatics Institute (Cambridgeshire, United Kingdom, software 
available from http://www.ebi.ac.uk/Tools/ clustalw2/index.html) to compare 
identity, strong similarity and similarity of the putative HCCA isomerase to those 
of other sphingomonads. Only the putative coding region of the nucleotide 
sequence was used for ClustalW2 alignment. 
Sub-cloning nahD into Escherichia coli 
The putative nahD gene from EPA 505 was sub-cloned into a pET-30 vector 
and transformed into a strain of E. coli suitable for plasmid maintenance. The 
plasmid was then extracted and transformed into another strain of E. coli suitable 
for protein expression. Successful transformations were confirmed by growth on 
selective media and by colony PCR targeting the vector on each side of the 
cloning site. 
Sub-cloning was accomplished using a Novagen® pET-30 Ek/LIC kit (Cat. 
#69077-3) from EMD Biosciences (Darmstadt, Germany). Host strains E. coli 
NovaBlue competent cells (for plasmid maintenance) and E. coli 
BL21(DE3)pLysS competent cells (for protein expression) were provided with the 
kit. The pET-30 Ek/LIC vector required the insert to have T4 DNA polymerase 
specific 5’ and 3’ extensions for ligation independent cloning (LIC) into the vector. 
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The pET-30 vector itself carried a kanamycin resistance marker, and pLysS 
carried a chloramphenicol resistance marker.  
PCR primers were designed with 14 bp T4 DNA polymerase specific 
extensions that would allow single-strand exonuclease activity to create 
compatible overhangs for ligation independent cloning into the pET-30 vector. 
Forward primer (5’ GAC GAC GAC AAG ATG ACC CGC AAG ATC GAC 3’) with 
Tm of 64.9
oC, designated “Ferdinand,” targeted the non-coding strand at the start 
codon, and included a 14 bp extension recognizable by T4 polymerase. Reverse 
primer (5’ GAG GAG AAG CCC GGT CCC TAT TTT TCT AAG 3’) with Tm of 
61.4oC, designated “Rumpelstiltskin,” targeted the coding strand at the stop 
codon, and included a 14 bp extension for T4 polymerase. Forward primer 
Ferdinand and reverse primer Rumpelstiltskin were obtained from IDT (Coralville, 
IA) and diluted in nuclease-free H2O to 10 μMol. The entire PCR amplified 
product should be 616 bp based on the sequencing data. 
The PCR reaction was assembled with the following: 2 μL isolated EPA 505 
DNA template, 2 μL forward primer Ferdinand (10 μMol), 2 μL reverse primer 
Rumpelstiltskin (10 μMol), 19 μL H2O and 25 μL GoTaq® Green MasterMix. PCR 
reaction was carried out in a Genius thermocycler with heated lid. Reaction was 
as follows: 95oC initial denaturation for 2 minutes; 30 cycles of 95oC for 45 
seconds, 58oC for 45 seconds and 72oC for 45 seconds; final elongation at 72oC 
for 2 minutes, then held at 4oC. The PCR product was then purified using 
QIAquick® PCR purification kit from QIAGEN (Valencia, CA) following 
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manufacturer’s instructions as outlined above. The eluted DNA was then 
checked for concentration and purity by OD260 and OD260/280. Then 5 μL PCR 
reaction and 5 μL purified PCR product were analyzed by agarose gel 
electrophoresis as described previously. 
The purified PCR product was then treated for insertion into the vector by T4 
DNA polymerase following the manufacturer’s instructions as follows. The 
following were assembled in a 1.5 mL microfuge tube on ice: 3 μL (0.2 pmol) 
purified PCR product, 2 μL 10X T4 DNA polymerase buffer, 2 μL of 25 mM 
dATP, 1 μL of 100 mM DTT, 11.6 μL nuclease-free H2O and 0.4 μL of 2.5 U/μL 
T4 DNA polymerase for a total reaction volume of 20 μL. The reaction was 
incubated at 22oC for 30 minutes, and then the enzyme was inactivated by 
incubation at 75oC for 20 minutes. 
The prepared insert was then annealed to the pET-30 Ek/LIC vector by 
assembling the following components in a 1.5 mL microfuge tube: 1 μL pET-30 
Ek/LIC vector and 2 μL treated insert. This was incubated at 22oC for 5 minutes 
before adding 1 μL of 25 mM EDTA and incubating for an additional 5 minutes. 
The annealing reaction was then transformed into E. coli NovaBlue 
competent cells. The competent cells were removed from -80oC storage and 
allowed to thaw on ice for 2 minutes. The tube was gently flicked to resuspend 
the 50 μL of cells, and then 1 μL of annealing reaction was added and stirred 
with a sterile pipet tip. This was incubated on ice for 5 minutes. The tube was 
then heated for 30 seconds in a 42oC water bath and returned to ice for 2 
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minutes. After incubation, 250 μL of room temperature SOC medium was added 
and incubated at 37oC for 1 hour with 200 rpm in a G24 Environmental Incubator 
Shaker. Lastly, 50 μL of transformation culture was plated onto each of two LB 
plates with 30 μg/mL kanamycin A from Sigma Chemical (St. Louis, MO) and 
incubated overnight at 37oC. 
Colonies able to grow on LB/kanamycin were checked by colony PCR to 
verify the presence of vector and insert, ensuring a successful transformation. 
PCR primers were designed to target sites upstream and downstream of the 
insert cloning site for amplification. Forward primer (5’ TAA TAC GAC TCA CTA 
TAG GGG 3’) with Tm of 50.1
oC, designated “T7 promoter,” targeted the T7 
promoter sequence of non-coding strand 221 bp upstream of the insert cloning 
site. Reverse primer (5’ TGC TAG TTA TTG CTC AGC GG 3’) with Tm of 55.0
oC, 
designated “T7 terminator,” targeted the T7 terminator sequence of the coding 
strand 164 bp downstream of the insert cloning site. Forward primer T7 promoter 
and reverse primer T7 terminator were obtained from IDT (Coralville, IA) and 
diluted in nuclease-free H2O to 10 μMol. The entire PCR amplified product 
should be 973 bp if the colony contains pET-30 with the proper insert. The PCR 
product should be only 385 bp if the colony contains pET-30 without any insert, 
and no PCR product should be formed if the colony does not contain pET-30. 
Six colonies were picked with sterile toothpicks from the transformation plates 
and touched to a reference plate of LB/kanamycin before transferring each of the 
colonies to 0.5 mL tubes with 50 μL sterile water. The cell suspensions were 
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vortexed thoroughly and boiled for 5 minutes to lyse the cells followed by 
centrifugation at 10,000 x g for one minute to pellet cell debris. The supernatant 
was then used as template DNA for colony PCR. 
The colony PCR reaction was assembled with the following: 10 μL 
supernatant DNA template, 1 μL forward primer T7 promoter (10 μMol), 1 μL 
reverse primer T7 terminator (10 μMol), 13 μL H2O and 25 μL GoTaq® Green 
MasterMix. PCR reaction was carried out in a Genius thermocycler with heated 
lid. The reaction was as follows: 95oC initial denaturation for 2 minutes; 30 cycles 
of 95oC for 45 seconds, 58oC for 45 seconds and 72oC for 45 seconds; final 
elongation at 72oC for 2 minutes, then held at 4oC. The PCR reaction was 
analyzed by agarose gel electrophoresis as described previously to determine 
PCR product size. 
One of the reference colonies that was determined to be a successful 
transformant was used for long-term storage and all subsequent work. The 
reference colony of E. coli NovaBlue recombinant with pET-30 containing the 
nahD insert was inoculated into 5 mL LB/kanamycin and incubated at 37oC 
overnight with 200 rpm shaking in a G24 Environmental Incubator Shaker. Once 
the culture had reached OD600 of 0.605, 0.9 mL culture was added to 0.1 mL of 
80% glycerol to make an 8% glycerol stock culture that was stored at -80oC. 
The NovaBlue recombinant was useful for the initial transformation and for 
plasmid maintenance, but nahD needed to be further sub-cloned into E coli 
BL21(DE3)pLysS to be useful for protein expression. This second sub-cloning 
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was accomplished by plasmid extraction from recombinant NovaBlue and 
transformation of the plasmid into BL21(DE3)pLysS. Successful transformation 
was judged by ability to grow on kanamycin and chloramphenicol, as pET-30 
Ek/LIC and pLysS confer resistance to these antibiotics, respectively. 
Transformants were also verified by colony PCR as before. 
NovaBlue recombinants were cultured for plasmid extraction. A streak 
isolation was performed onto LB with 30 μg/mL kanamycin A from the stock 
glycerol culture. This was incubated overnight at 37oC. An isolated colony was 
inoculated into 10 mL LB/kanamycin and cultured for 12 hours until reaching 
OD600 of 0.618. This was then used for plasmid extraction with a Wizard® Plus 
SV Miniprep DNA Purification System from Promega (Madison, WI) following 
manufacturer’s instructions as follows. Cells from 10 mL culture were harvested 
by centrifugation at 10,000 x g for 5 minutes. The supernatant was removed, and 
250 μL Cell Resuspension Solution was added and pipetted in and out to 
resuspend cells, and then it was transferred to a 1.5 mL microfuge tube. After 
complete cell resuspension, 250 μL Cell Lysis Solution was added, and the tube 
was inverted four times to mix. This was allowed to incubate at room temperature 
for 5 minutes while cell lysis occurred. Then 10 μL Alkaline Protease Solution 
was added and mixed by inversion of the tube four times. This was allowed to 
incubate for an additional 5 minutes. Next, 350 μL Neutralization Solution was 
added and mixed by inversion of the tube 4 times. The cell debris was then 
pelletted by centrifugation at 10,000 x g for 10 minutes. Then 850 μL of the 
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supernatant lysate was transferred to a Spin Column inside a collection tube and 
centrifuged at 10,000 x g for 1 minute. The flow through was discarded, and 
750 μL Column Wash Solution was added to the Spin Column. This was 
centrifuged at 10,000 x g for 1 minute, the flow through was discarded, and the 
wash procedure was repeated with 250 μL Column Wash Solution. The dry Spin 
Column was transferred to a clean 1.5 mL tube, and the DNA was eluted by 
addition of 100 μL nuclease-free H2O followed by centrifugation for 1 minute. The 
concentration and purity of the DNA were checked by OD260 and OD260/280. The 
DNA was also analyzed by agarose gel electrophoresis as described previously. 
The plasmid should be approximately 6000 bp with the insert. 
The purified plasmid was then transformed into BL21(DE3)pLysS competent 
cells. The competent cells were removed from -80oC storage and allowed to thaw 
on ice for 2 minutes. The tube was gently flicked to resuspend the 20 μL of cells, 
and then 1 μL of a 1:10 dilution recombinant plasmid (approximately 3-4 ng) was 
added and stirred with pipet tip. This was incubated on ice for 5 minutes. The 
tube was then heated for 30 seconds in a 42oC water bath and returned to ice for 
2 minutes. After incubation, 250 μL of room temperature SOC medium was 
added and incubated at 37oC for 1 hour with 200 rpm in a G24 Environmental 
Incubator Shaker. Lastly, 50 μL of transformation culture was plated onto each of 
two LB plates with 30 μg/mL kanamycin A and 34 μg/mL chloramphenicol from 
Sigma Chemical (St. Louis, MO) and incubated overnight at 37oC. 
Three colonies were subjected to colony PCR with the T7 promoter primer 
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and the T7 terminator primer as outlined above. PCR products were analyzed by 
agarose gel electrophoresis as described previously. One reference colony 
judged to be a successful transformant was chosen to be prepared as a stock 
culture. It was cultured in 5 mL LB with 30 μg/mL kanamycin A and 34 μg/mL 
chloramphenicol and 0.5% glucose to inhibit transcription of nahD. This was 
incubated at 30oC overnight with 200 rpm shaking in G24 Environmental 
Incubator Shaker until reaching OD600 of 0.938. Then 0.9 mL culture was added 
to 0.1 mL of 80% glycerol to make an 8% glycerol stock culture which was frozen 
and stored at -80oC. This recombinant BL21(DE3)pLysS with nahD was used in 
all subsequent work. 
The insert was also re-sequenced to verify successful sub-cloning. PCR with 
the T7 promoter and T7 terminator primers was again performed as described 
above. The PCR product was purified with the QIAquick® PCR purification kit 
from Qiagen (Valencia, CA) and sent to CUGI (Clemson, SC) with the forward 
and reverse primers for sequencing. 
Protein expression 
Expression of nahD in BL21(DE3)pLysS recombinants was performed and 
analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE). First, a small scale induction assay was performed to analyze protein 
expression, then a medium scale culture was induced for protein harvest.  
A streak isolation of recombinant BL21(DE3)pLysS was performed onto 
LB/kanamycin/chloramphenicol and incubated at 30oC overnight. An isolated 
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colony was inoculated into 5 mL of LB/kanamycin/chloramphenicol and incubated 
at 30oC overnight with 150 rpm in a Lab-line Orbit Microprocessor Shaker Bath 
from Thermo Scientific (Waltham, MA). Once the culture had reached OD600 of 
0.712, 4 mL of the overnight culture was added to a fresh 100 mL of 
LB/kanamycin/chloramphenicol in a 500 mL erlenmeyer flask and kept at 30oC 
with 150 rpm shaking. After 3.5 hours of incubation, the culture reached OD600 of 
0.677. The culture was aseptically separated into two 50 mL cultures, each in a 
250 ml flask. The lac promoter inducer isopropylthiogalactoside (IPTG) was 
added to only one flask to a final concentration of 1 mM. Both cultures continued 
under the same condition for an additional six hours, and 1 mL samples were 
taken at 0,1, 2, 4, and 6 hours. The samples were tested for OD600 and prepared 
for SDS-PAGE analysis. One mL of culture was centrifuged at 10,000 x g for one 
minute, and the supernatant discarded. The cell pellet was resuspended in 
100 μL phosphate buffer solution (PBS) for a 10X concentration. Then 100 μL 
sample loading buffer was added, and the samples were boiled for 3 minutes. 
Each of the samples was then loaded onto two polyacrylamide gels from Bio-Rad 
(Hercules, CA). The first gel was an 18-well 10% Tris-HCl (cat. #345-0010), and 
30 μL of each sample was loaded as well as 7 μL Precision Plus All Blue 
Standards (cat. #161-0373) and electrophoresed at 200V for one hour. The 
second gel was a 12-well 4-10% Tris-HCl (cat. #161-1173), and 20 μL of each 
sample was loaded as well as 10 μL Precision Plus All Blue Standards and 
electrophoresed at 100V for 1.75 hours. The gels were stained with Coomassie 
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Blue stain overnight with gentle rocking, then destained with 1% acetic acid and 
photographed. 
A similar procedure was conducted with a mid-size induced culture for 
harvesting the expressed enzyme HCCA isomerase. A 125 mL flask with 25 mL 
LB with 30 μg/mL kanamycin A and 34 μg/mL chloramphenicol was inoculated 
with three colonies of BL21(DE3)pLysS recombinants from a 24 hour streak 
isolation. The culture was incubated overnight at 30oC with 150 rpm shaking in a 
Lab-line Orbit Microprocessor Shaker Bath until reaching OD600 of 1.251. At this 
point, the culture was added to 500 mL of fresh medium in a 2 L flask, and 
incubation continued under the same conditions. After 2.5 hours the OD600 was 
0.771, and the culture was induced with 1mM IPTG. Four hours after induction 
the culture was aliquotted into polypropylene, conical bottom centrifuge tubes 
and centrifuged at 4oC and 3,900 x g for 20 minutes in an Allegra™ X-22R 
centrifuge with a SX4250 rotor from Beckman Coulter (Fullerton, CA). The 
supernatant was removed, and the cell pellet was washed by resuspension in 
one-tenth volume cold PBS followed by centrifugation for an additional 20 
minutes at 4oC and 3,900 x g. The supernatant was discarded, and the cell pellet 
was stored at -20oC. 
Protein purification 
Since BL21(DE3)pLysS has plasmid encoded lysozyme, the cell culture need 
only be subjected to a freeze thaw method to ensure lysis. Purification of HCCA 
isomerase from the lysate was facilitated by its histidine tagged leader peptide. 
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The fusion recombinant protein made possible by the pET-30 Ek/LIC vector is 
easily purified by Ni2+ affinity chromatography. Analysis of protein purity was 
determined by SDS-PAGE, and determination of protein concentration was by 
UV spectrometry. 
Cell lysis was induced by the addition of room temperature, autoclaved buffer 
(20 mM NaH2PO4, 500 mM NaCl, pH 7.5) to the frozen cell pellet. Only 20 mL 
buffer was used for resuspension of the pellet from 500 mL original culture, 
creating a 25X concentration of lysate. The cell suspension was pipetted in and 
out and vortexed to thoroughly mix. Filter-sterilized phenylmethylsulfonylfluoride 
(PMSF) was added to a final concentration of 1 mM to inhibit protease activity. 
The solution was then incubated on ice for 45 minutes to allow time for the 
lysozyme to take effect. Incubation continued at 4oC on a rocking platform from 
Bellco® Biotechnology (Vineland, NM) for an additional 15 minutes. At this point 
Triton X-100 was added to a final concentration of 1% (v/v), DNase I  from Fisher 
Scientific (Bohemia, NY) to 10,000 Units/mL and RNase from EMD Biosciences 
(Darmstadt, Germany) to a final concentration of 5 μg/mL. Incubation at 4oC with 
rocking continued for an additional 10 minutes. The lysate was then centrifuged 
at 4oC and 3,500 x g for 30 minutes in a Beckman Coulter Allegra™ X-22R 
centrifuge with SX-4250 rotor to pellet the cell debris.  The supernatant was 
removed by pipetting and filtered through 0.22 μm filter paper from Whatman 
(Maidstone, UK) to reduce viscosity. 
The Ni2+ affinity column was prepared by packing a small amount of glass 
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wool into the bottom of a 3cc polypropylene syringe. Enough HisLink™ resin 
from Promega (Madison, WI) was added for a 1 mL settled volume. The column 
was equilibrated with 5 mL binding buffer (100 mM HEPES, 500 mM NaCl, 
10 mM imidazole, pH 7.5) which flowed at approximately 1-2 mL/minute. After 
the binding buffer had completely entered the column, the filtered lysate was 
added 1-2 mL at a time. A total of 8 mL lysate was added, and it flowed through 
the column at about 0.2 mL/min. The resin column was then washed with 20 mL 
of wash buffer (100 mM HEPES, 500 mM NaCl, 20 mM imidazole, pH 7.5) with a 
flow rate of 1-2 mL/min. Next, 10 mL elution buffer (100 mM HEPES, 500 mM 
imidazole, pH 7.5) was added with a flow rate of 1-2 mL/min., and 1 mL elution 
fractions were collected. 
The10 elution fractions were analyzed by SDS-PAGE to determine the purity 
of HCCA isomerase recombinant protein. From each of the elution fractions, 
30 μL was added to 10 μL of 4X SDS sample buffer and boiled for 3 minutes. 
Then all 40 μL of each of the first 9 samples was loaded into a 10-well, 10% Tris-
HCl polyacrylamide gel (cat. #161-1155) from Bio-Rad (Hercules, CA) with 10 μL 
Kaleidoscope Prestained Standards (cat. #161-0324, also from Bio-Rad) in the 
first lane. The gel was run at 150V for 1.5 hours, stained overnight with 
Coomassie Blue on a rocking platform, then destained with 1% acetic acid and 
photographed. 
Protein concentration was determined by ultraviolet spectrophotometry using 
the Warburg formula with OD260, OD280 and OD320 on the BioPhotometer from 
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Eppendorf (Hamburg, Germany). The spectrophotometer was blanked with 
elution buffer, and then each of the 10 elution fractions was tested. 
Three of the best elution fractions based on SDS-PAGE and spectrometry 
analysis were then prepared for long-term storage at -20oC. Glycerol was added 
to a final concentration of 25%, EDTA to a final concentration of 1 mM and PMSF 






Sequence and analysis of nahD 
PCR from S. paucimobilis EPA505 chromosomal DNA targeting the putative 
nahD was performed three times with primers Fred and Renée. The 
concentrations and purity of DNA products were 41.3 μg/mL with OD260/280 of 
1.81, 39.6 μg/mL with OD260/280 of 1.82, and 42.4 μg/mL with OD260/280 of 1.79 for 
the three samples. Gel electrophoresis of each of the three samples showed 
products of slightly less than 1000 bp. Gel electrophoresis is shown in Figure 4.1. 
 A B C 
    
 Figure 4.1: Gel electrophoresis of putative nahD from S. paucimobilis EPA505. 
Lane 1 of each gel was 6 μL of Promega BenchTop 1kb DNA Ladder with 
fragment lengths of 10,000, 8,000, 6,000, 5,000, 4,000, 3,000, 2,500, 2,000, 
1,500, 1,000, 750, 500 and 250 bp. Sizes are marked for the last four bands. 
Lane 2 of each of the gels was 5 μL PCR sample + 1 μL 6X loading dye. 
Sequencing of the PCR product targeting the putative nahD from EPA505 
resulted in six sequences—each strand sequenced from three reactions. The six 
sequences were assembled in Sequencher™, and the result is shown in Figure 
4.2. The putative start codon ATG and stop codon TAG were identified based on 
nucleotide and amino acid sequences of HCCA isomerases from other species. 
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Figure 4.2: Sequence of putative nahD from S. paucimobilis EPA505. The 
putative start and stop codons of nahD are underlined. This sequence represents 
the assembly of six repetitions of sequencing. 
 
Figure 4.3 Translation of nahD from S. paucimobilis EPA505 
The sequence was analyzed by BLAST, and the results indicated strong 
matches to several previously sequenced HCCA isomerases from other species. 
The translated nucleotide sequence was then further compared to some of the 
top BLAST matches. Three were chosen for further comparison by ClustalW2 
alignment—Sphingobium yanoikuyae, Sphingomonas chungbukensis and 
Novosphingobium aromaticivorans. All four species showed 75% identity, 9% 
MTRKIDFYFDFISPFSYLAQLKLPEIARKAGCELEYWPIDIPEAKIAAGN  50 
YGPSNREVVPKIKVMMADLNRWARKYDAPLRFPASFACKDWNCATLYARE  100 
QGKAGAFVAAAYNRIWGQGIDPSDREELRACAAEAGLDAEALTAFVDSSL  150 
GQNEYRKVRSQAYQRGVFGAPLMFVDDEIFWGNDRLEFLEEYLEKxxxxx  195 
  1 TCCAGCAGATTCAAAACACGCTCGCAGTGAGGCAAACCGTGCCCAAGGGT 





















strong similarity and 8% weak similarity. The ClustalW2 alignment is shown in 
Figure 4.4. Interestingly, the peptide from EPA505 is two amino acids shorter 
than the other three sphingomonads. 
 
Figure 4.4: ClustalW2 alignment of HCCA isomerase from three species. 
ClustalW2 alignment of HCCA isomerase from S. paucimobils EPA505, 
Sphingobium yanoikuyae, Sphingomonas chungbukensis and Novosphingobium 
aromaticivorans. Symbol key: * = identity, : = strong similarity, . = weak 
similarity. 
Sub-cloning nahD into E. coli 
PCR amplification of the putative nahD from EPA505 with primers Ferdinand 
and Rumpelstiltskin was analyzed by OD260 and OD260/280 for concentration and 
purity, respectively. The concentration of DNA in the purified PCR reaction was 
12.2 μg/mL, and the OD260/280 was 1.85. Gel electrophoresis of the PCR product 
and purified PCR product showed bands for both gels between 500 and 750 bp 
in length. Gel electrophoresis is shown in Figure 4.5. 
XXXXXXXXXXXXEPA505 MTRKIDFYFDFISPFSYLAQLKLPEIARKAGCELEYWPIDIPEAKIAAGNXX50 
XXXXXS. yanoikuyae MSRKIDFYFDFISPFSYLAQLKLPEIARKAGCELQYWPIDIPEAKIAAGNXX50 
XXS. chungbukensis MTRTIDFYFDFISPFSYLAQLKLPGIARAAGSTVEYWPIDIPEAKIAAGNXX50 
N. aromaticovorans MTRTIDFYFDFISPFSYLAQLKLPEIARAAGCTVDYWPIDIPEAKIAAGNXX50 
 *:*.******************** *** **. ::*************** 
XXXXXXXXXXXXEPA505 YGPSNREVVPKIKVMMADLNRWARKYDAPLRFPASFACKDWNCATLYAREXX100 
XXXXXS. yanoikuyae YGPSNREVVPKIKVMMADLNRWAHKYDAPLRFPASFACKDWNCATLYAREXX100 
XXS. chungbukensis YGPSNREVLPKIKVMKADLERWAERYGVPLTFPASFACADWNCAVLFAREXX100 
N. aromaticovorans YGPSNREVLPKIKVMKADLERWAERYGVPLTFPASFACADWNCAVLFAREXX100 
 ********:****** ***:***.:*..** ******* *****.*:*** 
XXXXXXXXXXXXEPA505 QGKAGAFVAAAYNRIWGQGIDPSDREELRACAAEAGLDAEALTAFVDSSLXX150 
XXXXXS. yanoikuyae QGKAEAYVAAAYNLIWGQGIDPSDREELRACATEAGLDPEALTAFVDSSLXX150 
XXS. chungbukensis HGKAEAFVTDAYRRIWGQGIDPGDRNELAACAKAAGLDAEALIAFVESPTXX150 
N. aromaticovorans HGKAEAFVTDAYRRIWGQGIDPGDRNELAACAIAAGLDPAALIAFVESPAXX150 
 :*** *:*: **. ********.**:** ***  ****. ** ***:*.  
XXXXXXXXXXXXEPA505 GQNEYRKVRSQAYQRGVFGAPLMFVDDEIFWGNDRLEFLEEYLEKXXXXXXX195 
XXXXXS. yanoikuyae GQNEYRKARSLAYQRGVFGAPLMFVDDQIFWGNDRLDFLQEYLSQQKXXXXX197 
XXS. chungbukensis GQNEYRKARSQAIQRGVYGAPLMFVDDQFFWGKDRLDFLAEYLNKSKXXXXX197 
N. aromaticovorans GQNEYRKARSQAIQRGVYGAPLMFVDDQIFWGNDRLDFLAEYLNNSKXXXXX197 




Figure 4.5: Gel electrophoresis for PCR of nahD with T4 polymerase extensions. 
Lane 1 was 6 μL of Promega BenchTop 1kb DNA Ladder with fragment lengths 
of 10,000, 8,000, 6,000, 5,000, 4,000, 3,000, 2,500, 2,000, 1,500, 1,000, 750, 
500 and 250 bp. Last four bands labeled. Lane 2 was 5 μL PCR sample + 1 μL 
6X loading dye. Lane 3 was 5 μL purified PCR sample + 1 μL 6X loading dye. 
After the PCR product was annealed to pET-30 Ek/LIC and transformed into 
E. coli NovaBlue, 171 and 197 colonies grew on the two LB/kanamycin plates 
after 24 hours. Six of the colonies (three from each plate) were checked for 
presence of the insert by colony PCR using T7 promoter and T7 terminator 
primers. Gel electrophoresis of these PCR reactions showed four out of the six 
reactions to produce bands of lengths close to 1000 bp (lanes 1, 2, 4 and 6). One 
of the PCR reactions (lane 5) produced a fragment between 250 and 500 bp and 
another faint band between 500 and 750 bp. One PCR product did not produce 
any visible bands on the gel (lane 3). The gel electrophoresis is shown in 
Figure 4.6.  
Plasmid was extracted from a successful NovaBlue transformant, and the 
DNA concentration was found to be 34.8 μg/mL with OD260/280 of 1.83. Gel 
electrophoresis of the purified plasmid DNA produced a single band between 
5000 and 8000 bp in length. Gel electrophoresis is shown in Figure 4.7. 
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Figure 4.6: Gel electrophoresis of colony PCR from E. coli NovaBlue 
transformation. Lane 0 was 6 μL of Promega BenchTop 1kb DNA Ladder with 
fragment lengths of 10,000, 8,000, 6,000, 5,000, 4,000, 3,000, 2,500, 2,000, 
1,500, 1,000, 750, 500 and 250 bp. Lanes 1-6 were the colony PCR reactions 
from six different clones. 
 
Figure 4.7: Gel electrophoresis of plasmid purification from NovaBlue 
recombinant. Lane 1 was 6 μL of Promega BenchTop 1kb DNA Ladder with 
fragment lengths of 10,000, 8,000, 6,000, 5,000, 4,000, 3,000, 2,500, 2,000, 
1,500, 1,000, 750, 500 and 250 bp. Lane 2 was 5 μL isolated plasmid DNA from 
NovaBlue recombinants + 1 μL 6X loading dye. 
After the plasmid DNA from NovaBlue was transformed into 
BL21(DE3)pLysS, there were 81 colonies on the first LB/kanamycin/ 
chloramphenicol plate and 24 colonies on the dilution plate. Three colonies were 
tested by colony PCR using T7 promoter and T7 terminator primers, and all 
produced DNA fragments close to 1000 bp in length as did most of the PCR 
reactions from the NovaBlue testing. Gel electrophoresis is shown in Figure 4.8. 
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Figure 4.8: Gel electrophoresis of colony PCR for BL21(DE3)pLysS 
transformation. Lane 0 was 6 μL of Promega BenchTop 1kb DNA Ladder with 
fragment lengths of 10,000, 8,000, 6,000, 5,000, 4,000, 3,000, 2,500, 2,000, 
1,500, 1,000, 750, 500 and 250 bp. Lanes 1-3 were 5 μL colony PCR products 
with primers T7 promoter and T7 terminator + 1 μL 6X loading dye. 
Both strands of purified PCR product with T7 promoter and T7 terminator 
primers were sequenced by CUGI (Clemson, SC). The coding region of the 
resulting sequence matched perfectly with the previous sequencing results. The 
complete sequence obtained is shown in Figure 4.9. Approximately 30 bp of 
sequence was trimmed from each end, since the sequence was poor quality and 
inconclusive. 
Protein expression 
During the induction assay for protein expression of HCCA isomerase, the 
OD600 of both IPTG-induced and non-induced culture samples was monitored to 
ensure similarity in cell density and total-cell-protein quantities. The OD600 did, in 
fact, stay very similar for both cultures as seen in Figure 4.10. 
The SDS-PAGE results reveal heavy production of protein shortly after 
induction only in the induced culture. See Figures 4.11 and 4.12. The expressed 
protein visible on the gel was estimated to be between 25 and 37 kDa. All other  
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Figure 4.9: Sequence of pET-30 recombinant between T7 promoter & T7 
terminator. The start and stop codons of the coding region between the T7 
promoter and T7 terminator have been underlined. 
 
 
Figure 4.10: Cell density (OD600) of cultures for induction assay. Measurements 
of cell density based on OD600 began at induction with IPTG (0 hours). The 
spectrophotometer was blanked with LB. Samples at 4 and 6 hours were diluted 
50% in LB to stay within measureable range, and the OD600 values on the chart 



































Figure 4.11: SDS-PAGE of IPTG-induced and non-induced BL21(DE3)pLysS. 
The marker lane was loaded with 7 μL Bio-Rad Precision Plus All Blue Standards 
with marker sizes of 250, 150, 100, 75, 50, 37, 25, 20, 15 and 10 kDa. (Most of 
the marker bands are not clearly visible.) Each of the non-induced and IPTG-
induced lanes represents 30 μL of 10X concentrated sample with loading buffer. 
The expressed protein circled above was tentatively identified as HCCA 
isomerase. 
 
Figure 4.12: SDS-PAGE of IPTG-induced and non-induced BL21(DE3)pLysS. 
The marker lane was loaded with 10 μL Bio-Rad Precision Plus All Blue 
Standards with marker sizes of 250, 150, 100, 75, 50, 37, 25, 20, 15 and 10 kDa. 
Each of the non-induced and IPTG-induced lanes represents 20 μL of 10X 
concentrated sample with loading buffer. The expressed protein circled above 
was tentatively identified as HCCA isomerase. 
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protein bands appear very similar from both the induced and non-induced 
cultures. Two gels were run, as the results from only one were not conclusive 
enough. The first gel (Figure 4.11) clearly showed heavy production of the 
expressed protein in the IPTG-induced samples beginning one hour after 
induction and increasing with time, but the marker bands were unclear as they 
had been washed out with de-stainer. However, enough marker was present to 
extrapolate the estimated size of the expressed protein to be between 25 and 
37 kDa. The second gel (Figure 4.12) had clearly visible marker but only hazy 
representation of the expressed protein. It was more obvious on the second gel 
that the expressed protein was closer to the 25 kDa marker than the 37 kDa 
marker. The best representation of expressed protein on the second gel is seen 
in the 2 and 4 hour samples from the IPTG-induced culture. 
Protein purification 
The concentration and purity of histidine tagged HCCA isomerase eluted from 
the Ni2+ resin column was determined by spectrometry and SDS-PAGE. The 
Eppendorf BioPhotometer measures OD260, OD280 and OD320, and uses the 
Warburg formula to calculate protein concentration. The results are shown in 
Figure 4.13. The protein concentration values derived from a Warburg calculation 
are not exact, but should at least accurately reflect relative concentrations of 
protein from each elution fraction. The concentrations were highest in elutions 2-
6. The SDS-PAGE (Figure 4.14) clearly indicated large amounts of a protein of 
approximately 25-37 kDa being eluted from the column. Small amounts of 
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extraneous protein are still present in the first 3 mL eluted, but the remaining 
elutions appear very pure. 
 
Figure 4.13: Protein concentration of 1 mL fractions eluted from Ni2+ resin 
column. The fractions were 1 mL each. The Biophotometer was calibrated with 
elution buffer. 
 
Figure 4.14: SDS-PAGE of eluted fraction from Ni2+ resin column. Lane 0 was 
loaded with 10 μL Bio-Rad Kaleidoscope Prestained Standards with marker sizes 
of 250, 150, 100, 75, 50, 37, 25, 20, 15 and 10 kDa. Each of lanes 1-10 was 







































The most concentrated and most pure fractions were determined to be the 
4th, 5th and 6th based on spectrometry and SDS-PAGE. These were the 







Every line of evidence indicates that the putative nahD has been correctly 
identified and sub-cloned from S. paucimobilis EPA505. The PCR amplification 
from genomic DNA yielded fragments of approximately 1000 bp (see Figure 4.1), 
as expected. Preliminary sequencing data had indicated a predicted length of 
985 bp. The nucleotide sequence obtained was highly similar to previously 
published sequences belonging to HCCA isomerases from other species as 
shown by the BLAST queries, and the amino acid sequence is also highly similar 
to HCCA isomerases from other species as demonstrated by the ClustalW2 
alignment (see Figure 4.4).  The ClustalW2 alignment showed 75% identity and 
17% similarity for the enzyme between EPA505 and three other sphingomonads. 
PCR with T4 DNA polymerase extensions for insert of nahD into the pET-30 
Ek/LIC vector also appears to have been achieved. The PCR reaction should 
have produced a 616 bp fragment, and the gel in Figure 4.5 shows fragments 
between 500 and 750 bp. Colony PCR results indicate that nahD carried on the 
pET-30 vector was successfully sub-cloned into E. coli NovaBlue and 
BL21(DE3)pLysS. The primers used targeted the vector on each side of the 
insert cloning site. If the vector had not been transformed into E. coli, then no 
PCR product would form. This was seen in only one of the six reactions—the fifth 
colony from the NovaBlue transformation (see Figure 4.6). If the vector had 
closed on itself and been transformed into E. coli, then PCR would produce 
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fragments of 385 bp in length. This was also seen in one clone from the first 
NovaBlue transformation (see Figure 4.6). If the vector contained the 588 bp 
coding region from nahD, then PCR would produce fragments of 973 bp in 
length. This was seen in four of the first six reactions from the NovaBlue 
transformation (see Figure 4.6) and all three of the reactions from the 
BL21(DE3)pLysS transformation (see Figure 4.8). The plasmid also appears to 
have been isolated from NovaBlue for transformation into BL21(DE3)pLysS. The 
gel electrophoresis of isolated plasmid DNA showed a band corresponding to 
between 5000 and 8000 bp, and the pET-30 vector with the insert should be 
approximately 6000 bp. The insert region of the vector was re-sequenced in the 
final sub-clone, and the results completely matched the previous sequencing 
results (see Figures 4.2 and 4.9), showing that the integrity of DNA sequence 
had not been compromised in the cloning process.  
Expression and purification of HCCA isomerase also appears to be 
successful. Before the SDS-PAGE of an induction assay, the protein quantities 
loaded into the gel must be standardized to ensure a proper comparison. This 
was achieved by monitoring the cell densities of the induced and non-induced 
cultures. Since the OD600 of both cultures remained nearly identical (see 
Figure 4.10), then the protein sample load in the SDS-PAGE should also be 
comparable. The SDS-PAGE from the induction assay clearly showed 
expression of an approximately 25-37 kDa protein only after induction with IPTG 
(see Figures 4.11 and 4.12). The recombinant HCCA isomerase with fused 
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leader peptide was expected to be 27 kDa—22.2 kDa for the HCCA isomerase 
itself and 4.8 kDa for the vector coded leader peptide. Since the HCCA 
isomerase should be heavily transcribed after induction with IPTG, it was 
concluded that the dark protein bands circled in Figures 4.11 and 4.12 
correspond to this enzyme. This same 27 kDa protein is seen isolated after SDS-
PAGE of the Ni2+ affinity column purification (see Figure 4.14), indicating 
successful purification of the HCCA isomerase enzyme. 
These results strongly suggest that HCCA isomerase has been correctly 
identified, sequenced, sub-cloned, expressed and purified. The enzyme is most 
likely an integral part of PAH catabolism in S. paucimobilis EPA505 since it has 
been demonstrated to be essential in other species[19]. Further work should 
address the catalytic properties of the purified enzyme. The leader peptide could 
easily be cleaved by reaction with the peptidase enterokinase, leaving HCCA 
isomerase in its native form. The enzyme could then be reacted with its substrate 
2-hydroxychromene-2-carboxylate and with the supposed cofactor glutathione to 
determine if the expected product trans-o-hydroxybenzylidenepyruvate is indeed 
produced. Results of such a study could be conclusive but are not easily 
accomplished. The substrate is not commercially available or easily synthesized. 
Previous studies that accomplished the proposed assay did so by one of two 
methods. In the first method, 2-hydroxychromene-2-carboxylate was 
accumulated and purified from a culture containing knock-out mutants of the 
gene nahD. In the second method, both HCCA isomerase and the previous 
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enzyme of the naphthalene catabolic pathway 1,2-dihydroxynaphthalene 
dioxygenase were purified and reacted together with the previous substrate in 
the pathway 1,2-dihydroxynaphthalene, which is commercially available. 
Further studies should also include the other enzymes of the naphthalene 
catabolic pathway. There are six enzymes in the upper catabolic pathway. One 
has been successfully sub-cloned form EPA505 in this study, and two others are 
currently being researched. If all six enzymes were sub-cloned, expressed and 
purified, then the entire metabolic pathway could be demonstrated in vitro. 
Genetic organization and regulation of the metabolic pathway should also be 
researched. Large segments of plasmids or chromosomes coding for PAH 
catabolic genes have been published for a few species, but little understanding of 
the regulation and expression of these genes is available. 
The results of this study are one step in the progress to fully understand the 
polyaromatic hydrocarbon metabolism of sphingomonads, but such an 
understanding is necessary if the goal of bioremediation is to be achieved. The 
cost benefits could be great and the environmental impacts also greatly improved 
if bioremediation ever replaces costly traditional methods of remediation. Such 
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